Nasdaq:US$12.03 (-0.04) | HKEX:HK$19.00 (-0.90) | AIM:£1.93 (-0.05)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2009-11-05

Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans